冠状动脉穿孔的管理:从高容量中心逐步,基于病例的审查
Ahmed Elsherif1, Sophia Khattak2, Ameenathul Fawzy1
1Department of Cardiology, Queen Elizabeth Hospital, University Hospital, Birmingham NHS Trust, Birmingham, United Kingdom.
JACC. Case reports
|February 20, 2026
概括
冠状动脉穿孔 (CAP) 是穿皮冠状动脉干预的一种罕见但严重的并发症. 通过气球吸管及量身定制的干预措施及时管理,可以有效地预防死亡率和手术的需要.
科学领域:
- 干预心脏病学 干预心脏病学
- 心血管研究研究心血管研究
- 医疗器械技术 医疗器械技术
背景情况:
- 冠状动脉穿孔 (CAP) 是穿皮冠状动脉干预 (PCI) 的罕见但严重并发症.
- 它发生在0.2%~0.5%的常规PCI病例和高达3%的复杂手术中.
- 如果不及时有效地管理,CAP可能会危及生命.
研究的目的:
- 报告连续9起冠状动脉穿孔病例 (CAP) 的管理情况.
- 评估CAP结构化管理算法的有效性.
- 确定影响成功管理农业政策的关键因素.
主要方法:
- 在英国高等教育中心对9个连续的CAP案件进行了回顾性分析.
- 最初的治疗涉及所有患者的气球吸管.
- 最终的治疗方法包括覆盖式支架,线圈栓塞和自身凝块栓塞.
- 患者按埃利斯等级 (I-V) 分类,并相应地调整干预措施.
主要成果:
- 在9名患者中没有观察到住院死亡率.
- 四个病例是埃利斯三级,需要积极干预.
- 五名患者出现心周溢血,其中3人需要心周凝血.
- 在所有情况下都实现了成功的管理,而不需要手术救助.
结论:
- 一种结构化的 CAP 管理方法至关重要.
- 早期气球吸管,适当的设备选择和逐步升级是关键.
- 管理人员应考虑穿孔的严重程度,解剖位置和患者的血液动力学.
- 这种策略可以有效地预防死亡率,避免手术干预.
相关概念视频
Esophageal Perforation-II: Clinical Manifestations and Management
790
Esophageal perforations manifest in various clinical forms, influenced by factors such as the perforation's cause and location (cervical, intrathoracic, or intra-abdominal), the extent of contamination, and potential injury to adjacent mediastinal structures. The timing between the perforation occurrence and treatment initiation also affects the clinical presentation.
Clinical Manifestations:
Clinical Manifestations:
790
Acute Coronary Syndrome IV: Interprofessional Care
318
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
318
Coronary Artery Disease V: Interprofessional Care
321
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
321
Pericarditis III: Medical Management
407
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
407
Aneurysm III: Interprofessional Care
352
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
352
Angina IV: Management
344
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
344


